Utilization of biopsy-based genomic classifier to predict distant metastasis after definitive radiation and short-course ADT for intermediate and high-risk prostate cancer

被引：0
|
作者：
P L Nguyen
N E Martin
V Choeurng
B Palmer-Aronsten
T Kolisnik
C J Beard
P F Orio
M D Nezolosky
Y-W Chen
H Shin
E Davicioni
F Y Feng
机构：
[1] Dana-Farber/Brigham and Women’s Cancer Center and Harvard Medical School,Department of Radiation Oncology
[2] GenomeDx Biosciences,Department of Radiation Oncology
[3] University of California at San Francisco,undefined
来源：
Prostate Cancer and Prostatic Diseases | 2017年 / 20卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：186 / 192
页数：6
相关论文
共 50 条
  • [41] Propensity score matched analysis of metastasis-free survival for patients with high-risk prostate cancer treated with definitive radiation therapy or radical prostatectomy.
    Meeks, Marshall
    Markovina, Stephanie Subasic
    Vetter, Joel
    Paradis, Alethea
    Michalski, Jeff M.
    Sandhu, Gurdarshan Singh
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [42] Machine learning-based identification of high-risk bone metastasis factors after radical prostatectomy in prostate cancer
    Yang, Haijun
    Wei, Chengxiang
    Zhou, Shan
    Mao, Fei
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [43] Utilization of patient-reported outcomes to assess adherence to relugolix when combined with stereotactic body radiation therapy for intermediate to high-risk prostate cancer
    Gaudian, Kelly
    Koh, Min Jung
    Koh, Min Ji
    Collins, Ryan R.
    Eden, Shaine
    Zwart, Zoya
    Danner, Malika
    Zwart, Alan
    Fallick, Mark
    Kumar, Deepak
    Leger, Paul
    Dawson, Nancy A.
    Suy, Simeng
    Collins, Sean P.
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [44] The First Prostate Specific Antigen Value after Androgen Deprivation Therapy Initiation and after Definitive Radiation Therapy Completion As a Biomarker For Disease Relapse and Mortality in Intermediate and High Risk Prostate Cancer
    Patel, M. A.
    Kollmeier, M. A.
    McBride, S.
    Gorovets, D.
    Varghese, M.
    Knezevic, A.
    Zhigang, Z.
    Zelefsky, M. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E133 - E133
  • [45] Biochemical Relapse-free Survival after External Beam Radiation and Brachytherapy for Prostate Cancer Patients Having Intermediate and High-risk Features
    Shasha, D.
    Nabhani, T.
    Nadelson, A.
    Patton, B.
    Salant, R.
    Harrison, L. B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S337 - S337
  • [46] Long-term outcomes after treatment with brachytherapy and supplemental conformal radiation for prostate cancer patients having intermediate and high-risk features
    Dattoli, Michael
    Wallner, Kent
    True, Lawrence
    Cash, Jennifer
    Sorace, Richard
    CANCER, 2007, 110 (03) : 551 - 555
  • [47] Prostate-Specific Antigen Kinetics After Hypofractionated Stereotactic Body Radiation Therapy Boost and Whole-Pelvic Radiation Therapy for Intermediate- and High-Risk Prostate Cancer
    Kim, H. J.
    Kim, W. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E286 - E286
  • [48] Dynamic Changes of Molecular Subtype Classification and Genomic Classifier Scores in High-Risk Prostate Cancer Patients Undergoing Pre-Operative Stereotactic Body Radiation Therapy
    Diven, M.
    Hakansson, A.
    Liu, Y.
    Davicioni, E.
    Dillard, A.
    Khani, F.
    Wolfe, S.
    Hu, J. C.
    Scherr, D. S.
    McClure, T. D.
    Barbieri, C. E.
    Nagar, H.
    Marciscano, A. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E377 - E377
  • [49] Large institutional variations in use of androgen deprivation therapy with definitive radiotherapy in a population-based cohort of men with intermediate- and high-risk prostate cancer
    Ong, Wee Loon
    Foroudi, Farshad
    Evans, Sue
    Millar, Jeremy
    BJU INTERNATIONAL, 2017, 120 : 35 - 42
  • [50] Kallikrein markers performance in pretreatment blood to predict early prostate cancer recurrence and metastasis after radical prostatectomy among very high-risk men
    Assel, Melissa J.
    Ulmert, Hans David
    Karnes, R. Jeffery
    Boorjian, Stephen A.
    Hillman, David W.
    Vickers, Andrew J.
    Klee, George G.
    Lilja, Hans
    PROSTATE, 2020, 80 (01): : 51 - 56
12345